Literature DB >> 35293398

Platycodon grandiflorum root fermentation broth reduces inflammation in a mouse IBD model through the AMPK/NF-κB/NLRP3 pathway.

Zhe Wang1,2, Chunhai Li3, Xi He1,2, Kang Xu1,2, Zhipeng Xue1,2, Ting Wang1,2, Zhenshang Xu1,2, Xinli Liu1,2.   

Abstract

The effect of Platycodon grandiflorum (PG) on colitis and its underlying mechanism were rarely studied. In this study, Lactobacillus rhamnosus 217-1 was used to ferment PG roots, and the concentrations of platycodin-D, flavonoids, and polyphenols and the DPPH free radical scavenging rate were significantly increased. Treatment with a PG root fermentation broth (PGRFB) could reduce dextran sulfate sodium (DSS) induced ulcerative colitis (UC) in mice. Meanwhile, the PGRFB significantly reduced the content of inflammatory factors in mouse serum and the expression of inflammatory factor mRNA in the intestinal tract, regulated the polarization of M1/M2 macrophages, and increased the expression of tight junction protein mRNA in intestinal epithelial cells. In summary, it was proved that the PGRFB could inhibit the nuclear factor kappa B (NF-κB) signaling pathway and the expression of Nod-like receptor protein 3 (NLRP3) inflammasomes by activating AMP-activated protein kinase (AMPK) and lowering the release of pro-inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35293398     DOI: 10.1039/d1fo03969e

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  2 in total

1.  Renshen Baidu Powder Attenuated Intestinal Inflammation and Apoptosis in Ulcerative Colitis Rats through the Inhibition of PI3K/AKT/NF-κB Signaling Pathway.

Authors:  Peixu Zhang; Xiaobo Zhang; Peiyu Xiong; Chun Zhong; Zhen Zhou; Bo Jia; Xinglong Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-30       Impact factor: 2.650

Review 2.  Traditional Chinese medicine prescription Shenling BaiZhu powder to treat ulcerative colitis: Clinical evidence and potential mechanisms.

Authors:  Jing Chen; Bixin Shen; Zhengli Jiang
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.